RAB25 and breast carcinoma: Several studies on ovarian cancer [14], renal cell carcinoma [15, 16], luminal B breast cancer [12] and advanced non-small lung cancer [17] have described RAB25 as an oncogene, associated with metastasis and a poor prognosis.